Chemi SpA

Italian Company part of the ITALFARMACO Group. IP analysis expertise / forceful patent challenge skills. Diversified technology and skills in sophisticated molecules development & production. Qualified QC/QA department for analytical and regulatory development. Development and registration of dossiers for injectable and solid finished dosage forms. Company news: Chemi during the period July-August 2014 has received several approvals for the production of New generic APIs from the Health Authorities (HA): FDA has approved CHEMI for the manufacture of ENOXAPARIN SODIUM. FDA also approved CHEMI for production of SODIUM IBANDRONATE (injectable form). ANVISA (Brazilian HA) has approved CHEMI for the manufacture of SEVELAMER. PMDA (Japanese HA) has approved CHEMI for the manufacture of ZOLEDRONIC Acid.